The markets welcomed news that the FBI cleared Democratic presidential nominee Hillary Clinton of wrongdoing related to her handling of emails. Triple digit gains were posted by both with the Dow and Nasdaq with the blue chip index rocketing 371 points to 18,259. Nasdaq leaped 119 points to 5,166.
On the upside
Bain Capital Private Equity and Bow Street will take Blue Nile (Nasdaq: NILE) private for a premium of approximately $500 million in cash.
Amicus Therapeutics (Nasdaq: FOLD) reported third quarter revenue of $2.1 million compared with no revenue last year.
Datalink (Nasdaq: DTLK) will be acquired by Insight Enterprises (Nasdaq: NSIT) for a premium of approximately $258 million.
On the downside
HSN (Nasdaq: HSNI) disappointed with lower third quarter earnings and revenue.
The Patent and Trademark Office denied Coheres BioSciences' (Nasdaq: CHRS) petition for Inter Partes Review of Abbie's U.S. Patent 9,114,166 related to Abbie's HUMIRA formulation.
Shares of 500.com (NYSE: WBAI) plunged on no news.
In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 jumped 46 points to 2,131. Bitcoin fell $7 to $700.